These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8629287)

  • 1. New synthetic sulfated oligosaccharides prolong survival of cardiac xenografts by inhibiting release of heparan sulfate from endothelial cells.
    Deng S; Pascual M; Lou J; Bühler L; Wessel HP; Grau G; Schifferli JA; Morel P
    Transplantation; 1996 May; 61(9):1300-5. PubMed ID: 8629287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model.
    Leventhal JR; Matas AJ; Sun LH; Reif S; Bolman RM; Dalmasso AP; Platt JL
    Transplantation; 1993 Jul; 56(1):1-8. PubMed ID: 8333031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolongation of cardiac xenograft survival by depletion of complement.
    Leventhal JR; Dalmasso AP; Cromwell JW; Platt JL; Manivel CJ; Bolman RM; Matas AJ
    Transplantation; 1993 Apr; 55(4):857-65; discussion 865-6. PubMed ID: 8475561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo IgM depletion by anti-mu monoclonal antibody therapy. The role of IgM in hyperacute vascular rejection of discordant xenografts.
    Soares M; Lu X; Havaux X; Baranski A; Reding R; Latinne D; Daha M; Lambotte L; Bach FH; Bazin H
    Transplantation; 1994 Apr; 57(7):1003-9. PubMed ID: 8165695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of natural IgM in the hyperacute rejection of discordant heart xenografts.
    Gambiez L; Salame E; Chereau C; Calmus Y; Cardoso J; Ayani E; Houssin D; Weill B
    Transplantation; 1992 Oct; 54(4):577-83. PubMed ID: 1412747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection.
    Candinas D; Belliveau S; Koyamada N; Miyatake T; Hechenleitner P; Mark W; Bach FH; Hancock WW
    Transplantation; 1996 Dec; 62(12):1920-7. PubMed ID: 8990388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of xenoreactive antibody and B cell depletion on hyperacute rejection of guinea pig-to-rat cardiac xenografts.
    Pruitt SK; Baldwin WM; Barth RN; Sanfilippo F
    Transplantation; 1993 Dec; 56(6):1318-24. PubMed ID: 8278996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous infusion of Galalpha1-3Gal oligosaccharides in baboons delays hyperacute rejection of porcine heart xenografts.
    Simon PM; Neethling FA; Taniguchi S; Goode PL; Zopf D; Hancock WW; Cooper DK
    Transplantation; 1998 Feb; 65(3):346-53. PubMed ID: 9484750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of leflunomide and deoxyspergualin in the guinea pig-->rat cardiac model of delayed xenograft rejection: suppression of B cell and C-C chemokine responses but not induction of macrophage lectin.
    Hancock WW; Miyatake T; Koyamada N; Kut JP; Soares M; Russell ME; Bach FH; Sayegh MH
    Transplantation; 1997 Sep; 64(5):696-704. PubMed ID: 9311705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of graft preservation and IgM depletion on guinea pig to rat cardiac xenograft survival.
    Hori S; Havaux X; Rubay R; Latinne D; Bazin H; Gianello P
    Transplantation; 1997 Jun; 63(11):1554-61. PubMed ID: 9197345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil adhesion and complement inhibition prolongs survival of cardiac xenografts in discordant species.
    Zehr KJ; Herskowitz A; Lee PC; Kumar P; Gillinov AM; Baumgartner WA
    Transplantation; 1994 Mar; 57(6):900-6. PubMed ID: 8154039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccinia virus complement control protein inhibits hyperacute xenorejection in a guinea pig-to-rat heterotopic cervical cardiac xenograft model by blocking both xenoantibody binding and complement pathway activation.
    Anderson JB; Smith SA; van Wijk R; Chien S; Kotwal GJ
    Transpl Immunol; 2003; 11(2):129-35. PubMed ID: 12799195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection.
    Blakely ML; Van der Werf WJ; Berndt MC; Dalmasso AP; Bach FH; Hancock WW
    Transplantation; 1994 Nov; 58(10):1059-66. PubMed ID: 7974711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional activity of anti-C6 antibodies elicited in C6-deficient rats reconstituted by liver allografts. Ability to inhibit hyperacute rejection of discordant cardiac xenografts.
    Brauer RB; Baldwin WM; Wang D; Pruitt SK; Klein AS; Sanfilippo F
    Transplantation; 1996 Feb; 61(4):588-94. PubMed ID: 8610386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of antibody synthesis and complement activation in concordant xenograft retransplantation.
    Gannedahl G; Karlsson-Parra A; Wallgren A; Roos-Engstrand E; Nilsson B; Tötterman TH; Tufveson G
    Transplantation; 1994 Aug; 58(3):337-44. PubMed ID: 8053058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse-to-rabbit xenotransplantation: a new small animal model of hyperacute rejection mediated by the classical complement pathway.
    Kerr SR; Dalmasso AP; Apasova EV; Chen SS; Kirschfink M; Matas AJ
    Transplantation; 1999 Feb; 67(3):360-5. PubMed ID: 10030279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor and hyperacute rejection. The effect of a platelet-activating factor antagonist, SRI 63-441, on rejection of xenografts and allografts in sensitized hosts.
    Makowka L; Chapman FA; Cramer DV; Qian SG; Sun H; Starzl TE
    Transplantation; 1990 Sep; 50(3):359-65. PubMed ID: 2402783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival.
    Candinas D; Lesnikoski BA; Robson SC; Miyatake T; Scesney SM; Marsh HC; Ryan US; Dalmasso AP; Hancock WW; Bach FH
    Transplantation; 1996 Aug; 62(3):336-42. PubMed ID: 8779679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of hyperacute rejection in a rat-to-primate cardiac xenograft model.
    Azimzadeh A; Wolf P; Dalmasso AP; Odeh M; Beller JP; Fabre M; Charreau B; Thibaudeau K; Cinqualbre J; Soulillou JP; Anegon I
    Transplantation; 1996 May; 61(9):1305-13. PubMed ID: 8629288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor.
    Dalmasso AP; Platt JL
    Transplantation; 1993 Nov; 56(5):1171-6. PubMed ID: 8249120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.